Chugai Pharmaceutical Co., Ltd. 4519.T Stock
Chugai Pharmaceutical Co., Ltd. Price Chart
Chugai Pharmaceutical Co., Ltd. 4519.T Financial and Trading Overview
| Chugai Pharmaceutical Co., Ltd. stock price | 5107 JPY |
| Previous Close | 4146 JPY |
| Open | 4150 JPY |
| Bid | 4241 JPY x 0 |
| Ask | 4245 JPY x 0 |
| Day's Range | 4127 - 4249 JPY |
| 52 Week Range | 3191 - 4249 JPY |
| Volume | 4.21M JPY |
| Avg. Volume | 2.5M JPY |
| Market Cap | 6.99T JPY |
| Beta (5Y Monthly) | 0.488888 |
| PE Ratio (TTM) | 22.113932 |
| EPS (TTM) | 197.96 JPY |
| Forward Dividend & Yield | 80 (1.91%) |
| Ex-Dividend Date | June 29, 2023 |
| 1y Target Est | 4168.3 JPY |
4519.T Valuation Measures
| Enterprise Value | 6.29T JPY |
| Trailing P/E | 22.113932 |
| Forward P/E | 22.213497 |
| PEG Ratio (5 yr expected) | 10.72 |
| Price/Sales (ttm) | 5.7706914 |
| Price/Book (mrq) | 4.857809 |
| Enterprise Value/Revenue | 5.193 |
| Enterprise Value/EBITDA | 13.213 |
Trading Information
Chugai Pharmaceutical Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.488888 |
| 52-Week Change | 25.21% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4249 JPY |
| 52 Week Low | 3191 JPY |
| 50-Day Moving Average | 3625.54 JPY |
| 200-Day Moving Average | 3511.57 JPY |
4519.T Share Statistics
| Avg. Volume (3 month) | 2.5M JPY |
| Avg. Daily Volume (10-Days) | 2.9M JPY |
| Shares Outstanding | 1.64B |
| Float | 639.17M |
| Short Ratio | N/A |
| % Held by Insiders | 59.98% |
| % Held by Institutions | 19.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 78 |
| Trailing Annual Dividend Yield | 1.88% |
| 5 Year Average Dividend Yield | 159.00% |
| Payout Ratio | 0.4059 |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 26.09% |
| Operating Margin (ttm) | 36.69% |
| Gross Margin | 57.64% |
| EBITDA Margin | 39.30% |
Management Effectiveness
| Return on Assets (ttm) | 16.55% |
| Return on Equity (ttm) | 23.61% |
Income Statement
| Revenue (ttm) | 1.21T JPY |
| Revenue Per Share (ttm) | 736.57 JPY |
| Quarterly Revenue Growth (yoy) | -13.40% |
| Gross Profit (ttm) | 783.7B JPY |
| EBITDA | 476.23B JPY |
| Net Income Avi to Common (ttm) | 316.15B JPY |
| Diluted EPS (ttm) | 191.87 |
| Quarterly Earnings Growth (yoy) | -44.20% |
Balance Sheet
| Total Cash (mrq) | 554.61B JPY |
| Total Cash Per Share (mrq) | 337.12 JPY |
| Total Debt (mrq) | 0 JPY |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.893 |
| Book Value Per Share (mrq) | 873.439 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 299.32B JPY |
| Levered Free Cash Flow (ttm) | 244.3B JPY |
Profile of Chugai Pharmaceutical Co., Ltd.
| Country | Japan |
| State | N/A |
| City | Chuo |
| Address | 2-1-1 Nihonbashi-Muromachi |
| ZIP | 103-8324 |
| Phone | 81 3 3281 6611 |
| Website | https://www.chugai-pharm.co.jp |
| Industry | Drug Manufacturers-General |
| Sector(s) | Healthcare |
| Full Time Employees | 7771 |
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; Edirol, an Osteoporosis agent; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyroidism; and other diseases comprise Hemlibra, CellCept, Bonviva, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances and collaboration with Roche Group. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. operates as a subsidiary of Roche Holding Ltd.
Q&A For Chugai Pharmaceutical Co., Ltd. Stock
What is a current 4519.T stock price?
Chugai Pharmaceutical Co., Ltd. 4519.T stock price today per share is 5107 JPY.
How to purchase Chugai Pharmaceutical Co., Ltd. stock?
You can buy 4519.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Chugai Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Chugai Pharmaceutical Co., Ltd. is 4519.T.
Which industry does the Chugai Pharmaceutical Co., Ltd. company belong to?
The Chugai Pharmaceutical Co., Ltd. industry is Drug Manufacturers-General.
How many shares does Chugai Pharmaceutical Co., Ltd. have in circulation?
The max supply of Chugai Pharmaceutical Co., Ltd. shares is 1.65B.
What is Chugai Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Chugai Pharmaceutical Co., Ltd. PE Ratio is 25.79814000 now.
What was Chugai Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Chugai Pharmaceutical Co., Ltd. EPS is 197.96 JPY over the trailing 12 months.
Which sector does the Chugai Pharmaceutical Co., Ltd. company belong to?
The Chugai Pharmaceutical Co., Ltd. sector is Healthcare.
Chugai Pharmaceutical Co., Ltd. 4519.T included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Nasdaq Developed Select Leaders NQDMSLC | 1260.81 USD — |
0
|
— — | 1243.71 USD — | 1264.94 USD — | — - | — — |
| Nikkei 225 N225 | 39142.46 JPY 264.22 USD |
-0.96
|
— — | 38820.95 JPY 262.05 USD | 39170.35 JPY 264.41 USD | — - | — — |
| Nikkei 300 N300 | 587.56 JPY 3.97 USD |
-0.57
|
— — | 581.72 JPY 3.93 USD | 588.28 JPY 3.97 USD | — - | — — |
- {{ link.label }} {{link}}